These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3262066)
1. Both interleukin 1 and tumor necrosis factor enhance thymocyte proliferation. Hurme M Eur J Immunol; 1988 Aug; 18(8):1303-6. PubMed ID: 3262066 [TBL] [Abstract][Full Text] [Related]
2. Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor. Vink A; Uyttenhove C; Wauters P; Van Snick J Eur J Immunol; 1990 Jan; 20(1):1-6. PubMed ID: 2407536 [TBL] [Abstract][Full Text] [Related]
3. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes. Suda T; Murray R; Guidos C; Zlotnik A J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882 [TBL] [Abstract][Full Text] [Related]
4. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. Le JM; Vilcek J J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705 [TBL] [Abstract][Full Text] [Related]
5. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. Hernández-Caselles T; Stutman O J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382 [TBL] [Abstract][Full Text] [Related]
6. IL-7 is requisite for IL-1-induced thymocyte proliferation. Involvement of IL-7 in the synergistic effects of granulocyte-macrophage colony-stimulating factor or tumor necrosis factor with IL-1. Herbelin A; Machavoine F; Schneider E; Papiernik M; Dy M J Immunol; 1992 Jan; 148(1):99-105. PubMed ID: 1727878 [TBL] [Abstract][Full Text] [Related]
7. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway. Herbelin A; Machavoine F; Dy M Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117 [TBL] [Abstract][Full Text] [Related]
8. Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation. Davis L; Lipsky PE J Immunol; 1985 Nov; 135(5):2946-52. PubMed ID: 3876369 [TBL] [Abstract][Full Text] [Related]
9. Triggering of thymocyte function by IL-2 as the only exogenous stimulus; analysis of two distinct modes of IL-2-induced thymocyte proliferation and IL-3 secretion in vitro. Bellio M; Dos Reis GA Immunology; 1989 Oct; 68(2):175-80. PubMed ID: 2807375 [TBL] [Abstract][Full Text] [Related]
10. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production. Vine JB; Geppert TD; Lipsky PE J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha and P40 induce day 15 murine fetal thymocyte proliferation in combination with IL-2. Suda T; Murray R; Fischer M; Yokota T; Zlotnik A J Immunol; 1990 Mar; 144(5):1783-7. PubMed ID: 1968489 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation. Hackett RJ; Davis LS; Lipsky PE J Immunol; 1988 Apr; 140(8):2639-44. PubMed ID: 2965728 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. Jelinek DF; Lipsky PE J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883 [TBL] [Abstract][Full Text] [Related]
14. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Owen-Schaub LB; Gutterman JU; Grimm EA Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408 [TBL] [Abstract][Full Text] [Related]
15. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes. Davis L; Lipsky PE J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. Yokota S; Geppert TD; Lipsky PE J Immunol; 1988 Jan; 140(2):531-6. PubMed ID: 3257243 [TBL] [Abstract][Full Text] [Related]
18. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Lasky JL; Thorbecke GJ Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224 [TBL] [Abstract][Full Text] [Related]
19. Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha. Verstovsek S; Maccubbin D; Ehrke MJ; Mihich E Cancer Res; 1992 Jul; 52(14):3880-5. PubMed ID: 1617664 [TBL] [Abstract][Full Text] [Related]